Table 1.

Demographic characteristics at baseline

	TVDV* (1 mg)	TVDV* (1 mg) with Vaxfectin	TVDV* (2 mg) with Vaxfectin	Total
	(N = 10)	(N = 10)	(N = 20)	(N = 40)
Gender (%)
Male	5 (50)	8 (80)	9 (45)	22 (55)
Age at screening (years) mean (±SD)†	33.4 (9.3)	38.4 (9.7)	32.6 (10.6)	34.3 (10.1)
Race (%)
Caucasian	5 (50)	5 (50)	7 (35)	17 (42.5)
African-American	3 (30)	4 (40)	12 (60)	19 (47.5)
Asian	1 (10)	1 (10)	0 (0)	2 (5)
Other	1 (10)	0 (0)	1 (5)	2 (5)
Weight (lbs) mean (±SD)†	196.0 (45.5)	191.2 (26.2)	180.0 (32.5)	186.8 (34.7)

^*TVDV = tetravalent dengue DNA vaccine.

^†SD = standard deviation.